A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Investigational Site Number 83, Budapest

Investigational Site Number 61, København Ø

Investigational Site Number 51, Ghent

Investigational Site Number 26, Torino

Investigational Site Number 82, Praha 5 - Motol

Investigational Site Number 21, Genova

Investigational Site Number 24, Milan

Investigational Site Number 35, Hamburg

Investigational Site Number 93, Madrid

Investigational Site Number 31, Hanover

Investigational Site Number 23, Padua

Investigational Site Number 33, Frankfurt am Main

Investigational Site Number 81, Brno

Investigational Site Number 91, Tel Aviv

Investigational Site Number 42, Lyon

Investigational Site Number 43, Paris

Investigational Site Number 34, Freiburg im Breisgau

Investigational Site Number 36, München

Investigational Site Number 92, Petah Tikva

Investigational Site Number 22, Roma

Investigational Site Number 72, Amsterdam

Investigational Site Number 71, Rotterdam

Investigational Site Number 85, Krakow

Investigational Site Number 84, Wroclaw

Investigational Site Number 94, Barcelona

Investigational Site Number 11, Birmingham

Investigational Site Number 13, Glasgow